Equities

Rainmed Medical Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Rainmed Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)0.29
  • Today's Change0.01 / 3.57%
  • Shares traded10.00k
  • 1 Year change+98.63%
  • Beta0.6646
Data delayed at least 15 minutes, as of Feb 16 2026 03:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Rainmed Medical Ltd is an investment holding company. The Company is primarily engaged in research and development, manufacturing and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) system, coronary angiography-derived index of microvascular resistance (caIMR) system and in vitro diagnostic (IVD) products. The Company’s core products, caFFR system and caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). They are designed to eliminate the usage of pressure wires, significantly reduce the risk of technical errors and operation time, and improve physiological assessment. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)26.43m
  • Net income in HKD-117.68m
  • Incorporated2014
  • Employees214.00
  • Location
    Rainmed Medical LtdBlock 31, Northeast DistrictNo. 99 Jinjihu Avenue, Suzhou IndustriaSUZHOU ChinaCHN
  • Websitehttps://www.rainmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AMCO United Holding Ltd42.93m25.34m241.89m30.009.543.959.545.630.02620.02620.04440.06330.27322.194.481,430,967.0016.13-17.5231.44-28.5536.1926.8159.04-60.661.91--0.3507--10.07-11.0128.02------
Yestar Healthcare Holdings Co Ltd2.19bn-183.12m268.13m479.00--0.5047--0.1223-0.0785-0.07850.94070.22791.216.193.453,498,162.00-11.15-1.02-27.03-4.1516.2617.27-9.20-1.181.20-69.310.3503---17.26-13.249,987.0635.36-1.59--
Ziyuanyuan Holdings Group Ltd643.21m-59.12m296.70m44.00--0.8394--0.4613-0.1577-0.15771.590.8220.87168.972.605,145,658.00-7.92-0.1315-11.64-0.196511.70---9.09-0.22912.04-0.88550.444--10.9151.97-463.73---43.21--
Arts Optical International Holdings Ltd1.27bn-6.08m366.95m3.40k--0.68897.760.2888-0.0157-0.01573.291.380.94364.153.38353,004.700.0241-5.100.0527-10.4529.8727.650.0255-5.340.76492.160.273--7.194.26-77.75--55.71--
Rainmed Medical Ltd26.43m-117.68m406.39m214.00--0.7382--15.38-0.1004-0.10040.02250.39280.04231.194.6397,883.59-19.20---23.73--44.22---454.20--2.38--0.0766---45.61--2.02------
Austar Lifesciences Ltd1.65bn39.82m415.19m1.45k10.430.45354.260.25110.07770.07773.231.790.70174.861.541,144,142.001.584.003.519.1220.1822.092.264.391.1674.460.30590.00-14.937.42149.3114.728.35--
ClouDr Group Ltd2.55bn-1.07bn561.78m966.00--0.516--0.2201-1.82-1.824.321.690.86552.953.462,095,279.00-38.96-79.82-70.33--33.5026.37-45.01-74.910.9896-60.820.2871---5.4946.08-59.85--78.43--
Data as of Feb 16 2026. Currency figures normalised to Rainmed Medical Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.